“…From Table , Table S2, and Table , it can be seen that there is only one β-agonist (CL) with a detection limit of 0.1 ng·mL –1 in Table , four β-agonists (CL, SAL, RAC, and TUL) with a detection limit of 0.1 ng·mL –1 in Table S2, and six β-agonists (CL, SAL, RAC, TER, MAB, and TUL) with a detection limit of 0.1 ng·mL –1 in Table , which shows that the multiresidue detection performance of the GCE/GNP/RAC immunosensor is better than those of GCE/GNP/SAL and GCE/GNP/CL immunosensors. The three multiresidue immunosensors based on the anti-BSA-RAC-CL-SAL antibody manifest outstanding performance with a wide linear range and low detection limit, compared with the previous different material-modified electrodes for RAC detection, for example, Au/OMC/GCE (detection limit 1.49 ng·mL –1 ), 3D MnO 2 /RGO@nickel foam (detection limit 3.92 ng·mL –1 ), ATONPs/CNTs/GCE (detection limit 1.11 ng·mL –1 ), and MCF/CPE (detection limit 3.38 ng·mL –1 ), which can be ascribed to the high specific area of the GCE/GNP/β-agonist (RAC, CL, or SAL) caused by the nanoscale effect of the graphene, increasing the loading capacity of the β-agonists.…”